Allostimulated lymphocytes inhibit replication of HIV type 1

被引:29
作者
Bruhl, P
Kerschbaum, A
Zimmermann, K
Eibl, MM
Mannhalter, JW
机构
[1] IMMUNO AG WIEN,DEPT IMMUNOL RES,A-1221 VIENNA,AUSTRIA
[2] UNIV VIENNA,INST IMMUNOL,A-1090 VIENNA,AUSTRIA
关键词
D O I
10.1089/aid.1996.12.31
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Previous reports demonstrated that alloantigen- or xenoantigen-specific antibodies displayed neutralizing activity toward human or simian immunodeficiency viruses, In the present article we have addressed the question of alloantigen-induced cell-mediated anti-HIV activity, We show that allostimulation resulted in a lymphocyte population (largely of the CDS-positive phenotype) with the capacity to inhibit HIV-1 replication in PHA blasts of homologous and, unexpectedly, also autologous origin, The allostimulated effector cells exerted their activity via a noncytolytic mechanism: Experiments in which direct cell-to-cell contact between allostimulated effecters and HIV-1-infected PHA blasts was prevented by a semipermeable membrane indicated that soluble mediators were involved in inhibition of HIV-1 replication, As such allostimulated effecters not only would have the capacity to prevent viral replication in allogeneic HIV-l-infected cells (known to play an important role in HIV-1 transmission in vivo), but also might inhibit HIV-1 growth in autologous lymphocytes, the concept of an AIDS vaccine containing both HIV-1 antigens and alloantigens warrants further consideration.
引用
收藏
页码:31 / 37
页数:7
相关论文
共 29 条
[1]   CELLULAR PROTEINS BOUND TO IMMUNODEFICIENCY VIRUSES - IMPLICATIONS FOR PATHOGENESIS AND VACCINES [J].
ARTHUR, LO ;
BESS, JW ;
SOWDER, RC ;
BENVENISTE, RE ;
MANN, DL ;
CHERMANN, JC ;
HENDERSON, LE .
SCIENCE, 1992, 258 (5090) :1935-1938
[2]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[3]  
BRINCHMANN JE, 1990, J IMMUNOL, V144, P2961
[4]   SUPPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION BY CD8+ CELLS FROM INFECTED AND UNINFECTED CHIMPANZEES [J].
CASTRO, BA ;
WALKER, CM ;
EICHBERG, JW ;
LEVY, JA .
CELLULAR IMMUNOLOGY, 1991, 132 (01) :246-255
[5]  
CHAN WL, 1995, AIDS, V9, P223, DOI 10.1097/00002030-199509030-00002
[6]   PROTECTION IN SIMIAN IMMUNODEFICIENCY VIRUS VACCINATED MONKEYS CORRELATES WITH ANTI-HLA CLASS-I ANTIBODY-RESPONSE [J].
CHAN, WL ;
RODGERS, A ;
HANCOCK, RD ;
TAFFS, F ;
KITCHIN, P ;
FARRAR, G ;
LIEW, FY .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) :1203-1207
[7]   CD8(+) T-LYMPHOCYTE-MEDIATED INHIBITION OF HIV-1 LONG TERMINAL REPEAT TRANSCRIPTION - A NOVEL ANTIVIRAL MECHANISM [J].
CHEN, CH ;
WEINHOLD, KJ ;
BARTLETT, JA ;
BOLOGNESI, DP ;
GREENBERG, ML .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (11) :1079-1086
[8]  
DETELS R, 1995, 2ND NAT C HUM RETR R
[9]  
DULBECCO R, 1988, VIROLOGY, P22
[10]   CD8+ T-LYMPHOCYTES OF AFRICAN-GREEN MONKEYS SECRETE AN IMMUNODEFICIENCY VIRUS-SUPPRESSING LYMPHOKINE [J].
ENNEN, J ;
FINDEKLEE, H ;
DITTMAR, MT ;
NORLEY, S ;
ERNST, M ;
KURTH, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (15) :7207-7211